Naba Alsaha Medical Services Co. vs Dallah Healthcare Co.
A head-to-head of Naba Alsaha Medical Services Co. (9546) and Dallah Healthcare Co. (4004) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | 9546 | 4004 |
|---|---|---|
| Market Cap | 462.00M SAR | 10.78B SAR |
| P/E (TTM) | 8.16 | 20.02 |
| Forward P/E | — | 20.80 |
| P/S | 2.29 | 2.67 |
| P/B | 2.02 | 2.64 |
| EV/EBITDA | 13.43 | 20.79 |
| Dividend Yield | 70.00% | 1.79% |
| Profit Margin | 13.64% | 11.15% |
| Gross Margin | 32.80% | 35.71% |
| Operating Margin | 15.26% | 15.40% |
| Revenue Growth (YoY) | +5.80% | +21.68% |
| FCF Yield | — | -0.21% |
| Debt / Equity | 54.27 | 94.09 |
| Current Ratio | 6.26 | 1.20 |
Which is better: Naba Alsaha Medical Services Co. or Dallah Healthcare Co.?
- ✓Larger by market cap: Dallah Healthcare Co.
- ✓Cheaper valuation (lower P/E): Naba Alsaha Medical Services Co.
- ✓Higher dividend yield: Naba Alsaha Medical Services Co.
- ✓More profitable (net margin): Naba Alsaha Medical Services Co.
- ✓Faster revenue growth: Dallah Healthcare Co.
Across 11 available metrics, Naba Alsaha Medical Services Co. leads 8–3.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Naba Alsaha Medical Services Co. with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.